These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28981193)

  • 1. Organ utilization from increased infectious risk donors: An observational study.
    L'Huillier AG; Humar A; Payne C; Kumar D
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28981193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety.
    Irwin L; Kotton CN; Elias N; Palafox J; Basler D; Shao SH; Lester W; Zhang X; Kimball B; Trencher C; Fishman JA
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28994164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model to estimate the probability of human immunodeficiency virus and hepatitis C infection despite negative nucleic acid testing among increased-risk organ donors.
    Annambhotla PD; Gurbaxani BM; Kuehnert MJ; Basavaraju SV
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28178393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ transplantation from "increased infectious risk donors": the experience of the Nord Italia Transplant program - A retrospective study.
    Grossi PA; Dalla Gasperina D; Lombardi D; Ricci A; Piccolo G; Nanni Costa A
    Transpl Int; 2018 Feb; 31(2):212-219. PubMed ID: 29057524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Survey of Increased Infectious Risk Donor Utilization in Canadian Transplant Programs.
    Kumar D; Humar A; Kim SJ; Kiberd B
    Transplantation; 2016 Feb; 100(2):461-4. PubMed ID: 26285016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation.
    Da BL; Ezaz G; Kushner T; Crismale J; Kakked G; Gurakar A; Dieterich D; Schiano TD; Saberi B
    JAMA Netw Open; 2020 Dec; 3(12):e2027551. PubMed ID: 33275155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020.
    Jones JM; Kracalik I; Levi ME; Bowman JS; Berger JJ; Bixler D; Buchacz K; Moorman A; Brooks JT; Basavaraju SV
    MMWR Recomm Rep; 2020 Jun; 69(4):1-16. PubMed ID: 32584804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Deceased Solid Organ Donors and Screening Results for Hepatitis B, C, and Human Immunodeficiency Viruses - United States, 2010-2017.
    Abara WE; Collier MG; Moorman A; Bixler D; Jones J; Annambhotla P; Bowman J; Levi ME; Brooks JT; Basavaraju SV
    MMWR Morb Mortal Wkly Rep; 2019 Jan; 68(3):61-66. PubMed ID: 30677008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue donation and virus safety: more nucleic acid amplification testing is needed.
    Pruss A; Caspari G; Krüger DH; Blümel J; Nübling CM; Gürtler L; Gerlich WH
    Transpl Infect Dis; 2010 Oct; 12(5):375-86. PubMed ID: 20412535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of US Public Health Service increased risk deceased donor designation on organ utilization.
    Sapiano MRP; Jones JM; Bowman J; Levi ME; Basavaraju SV
    Am J Transplant; 2019 Sep; 19(9):2560-2569. PubMed ID: 30959569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deceased organ donor screening for HIV, hepatitis B, and hepatitis C viruses: a survey of organ procurement organization practices.
    Theodoropoulos N; Jaramillo A; Ladner DP; Ison MG
    Am J Transplant; 2013 Aug; 13(8):2186-90. PubMed ID: 23711196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of deceased organ donors based on HIV, hepatitis B virus, and hepatitis C virus screening test results.
    Theodoropoulos N; Kroll-Desrosiers A; Ison MG
    Transpl Infect Dis; 2020 Aug; 22(4):e13275. PubMed ID: 32144838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.
    Pruett TL; Clark MA; Taranto SE
    Transplantation; 2017 Jul; 101(7):1670-1678. PubMed ID: 28252560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
    Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
    Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ utilization among deceased donors in Canada, 1993-2002.
    Badovinac K; Greig PD; Ross H; Doig CJ; Shemie SD
    Can J Anaesth; 2006 Aug; 53(8):838-44. PubMed ID: 16873352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased-risk versus standard-risk donation in lung transplantation: A United Network of Organ Sharing analysis.
    Brown M; Kashem MA; Zhao H; Kehara H; Yanagida R; Shigemura N; Toyoda Y
    J Thorac Cardiovasc Surg; 2024 Jul; 168(1):299-307.e3. PubMed ID: 37689235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplant of organs from donors with positive SARS-CoV-2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee.
    Goldman JD; Pouch SM; Woolley AE; Booker SE; Jett CT; Fox C; Berry GJ; Dunn KE; Ho CS; Kittleson M; Lee DH; Levine DJ; Marboe CC; Marklin G; Razonable RR; Taimur S; Te HS; Anesi JA; Fisher CE; Sellers MT; Trindade AJ; Wood RP; Zaffiri L; Levi ME; Klassen D; Michaels MG; La Hoz RM; Danziger-Isakov L
    Transpl Infect Dis; 2023 Feb; 25(1):e14013. PubMed ID: 36694448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes of Liver Transplant Candidates Toward Organs From Increased-Risk Donors.
    Humar SS; Liu J; Pinzon N; Kumar D; Bhat M; Lilly L; Selzner N
    Liver Transpl; 2019 Jun; 25(6):881-888. PubMed ID: 30947392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deceased Organ Donors With a History of Increased Risk Behavior for the Transmission of Blood-Borne Viral Infection: The UK Experience.
    Trotter PB; Summers DM; Robb M; Hulme W; Ushiro-Lumb I; Watson CJE; Neuberger J; Bradley JA
    Transplantation; 2017 Jul; 101(7):1679-1689. PubMed ID: 28291157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ donor screening using parallel nucleic acid testing allows assessment of transmission risk and assay results in real time.
    Baleriola C; Tu E; Johal H; Gillis J; Ison MG; Law M; Coghlan P; Rawlinson WD
    Transpl Infect Dis; 2012 Jun; 14(3):278-87. PubMed ID: 22519518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.